Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

E1400000

Erythromycin estolate

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Erythromycin 2′-propionate dodecyl sulfate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
C40H71NO14 · C12H26SO4
CAS Number:
3521-62-8
Molecular Weight:
1056.39
MDL number:
MFCD00084691
UNSPSC Code:
41116107
PubChem Substance ID:
329799009
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

erythromycin

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

CCCCCCCCCCCCOS(O)(=O)=O.CC[C@H]1OC(=O)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(O)C[C@H](C)C(=O)C(C)[C@@H](O)[C@@]1(C)O

InChI

1S/C37H67NO13.C12H26O4S/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;2-12H2,1H3,(H,13,14,15)/t18-,19+,20?,21+,22-,23-,24-,25?,26-,28+,29+,30+,31-,32-,34-,35-,36+,37+;/m0./s1

InChI key

SKDGGFHGLZBNBC-CAHOBLCESA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Erythromycin estolate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

PHR1039

Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material

1242000

Erythromycin, United States Pharmacopeia (USP) Reference Standard

1242010

Erythromycin B, United States Pharmacopeia (USP) Reference Standard

1242021

Erythromycin C, United States Pharmacopeia (USP) Reference Standard

1242032

Erythromycin Related Compound N, United States Pharmacopeia (USP) Reference Standard

1245008

Erythromycin ethyl succinate, United States Pharmacopeia (USP) Reference Standard

E1310000

Erythromycin B, European Pharmacopoeia (EP) Reference Standard

E1320000

Erythromycin C, European Pharmacopoeia (EP) Reference Standard

E1500000

Erythromycin ethyl succinate, European Pharmacopoeia (EP) Reference Standard

E1300000

Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard

E1500800

Erythromycin stearate, European Pharmacopoeia (EP) Reference Standard

1243002

Erythromycin estolate, United States Pharmacopeia (USP) Reference Standard

1248006

Erythromycin stearate, United States Pharmacopeia (USP) Reference Standard

1247003

Erythromycin lactobionate, United States Pharmacopeia (USP) Reference Standard

PHR1610

Erythromycin Ethylsuccinate, Pharmaceutical Secondary Standard; Certified Reference Material

BP488

Erythromycin stearate, British Pharmacopoeia (BP) Reference Standard

BP781

Erythromycin, British Pharmacopoeia (BP) Reference Standard

BP889

N-Demethylerythromycin A, British Pharmacopoeia (BP) Reference Standard

BP798

Erythromycin ethyl succinate, British Pharmacopoeia (BP) Reference Standard

Pictograms

Health hazardExclamation mark
GHS08,GHS07

Signal Word

Danger

Hazard Statements

H302,H317,H334

Hazard Classifications

Acute Tox. 4 Oral - Resp. Sens. 1 - Skin Sens. 1

WGK

WGK 3

Regulatory Information

监管及禁止进口产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962.
F I Gilbert
Hawaii medical journal, 54(6), 603-605 (1995-06-11)
Soo-Jin Park et al.
Journal of colloid and interface science, 271(2), 336-341 (2004-02-20)
In this work, the producing of a biodegradable poly(l-lactide) (PLA)/poly(ethylene glycol) (PEG) microcapsule by emulsion solvent evaporation method was investigated. The effect of PEG segments added to the PLA microcapsules on the degradation, size distribution, and release behavior was studied.
Pidaran Murugan et al.
Journal of basic and clinical physiology and pharmacology, 16(1), 1-15 (2005-09-29)
Erythromycin estolate (EME), a potent macrolide antibiotic, generates free radicals, but their role in the development of liver toxicity is not yet well understood. The present study was carried out to investigate the effect of the antioxidant drug tetrahydrocurcumin (a
[Hepatotoxicity from erythromycin estolate].
S Saiz Santos et al.
Atencion primaria, 10(9), 1050-1050 (1992-12-01)
Joanne M Langley et al.
Pediatrics, 114(1), e96-101 (2004-07-03)
Although universal immunization against Bordetella pertussis (whooping cough) infection has resulted in dramatic reductions in the incidence of pertussis, outbreaks continue to occur in countries with excellent vaccine coverage. Treatment of infection may ameliorate symptom severity during the catarrhal phase
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service